Page last updated: 2024-10-30

ketotifen and Disease, Pulmonary

ketotifen has been researched along with Disease, Pulmonary in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flenley, DC1

Reviews

1 review available for ketotifen and Disease, Pulmonary

ArticleYear
New drugs in respiratory disorders: I.
    British medical journal (Clinical research ed.), 1983, Mar-12, Volume: 286, Issue:6368

    Topics: Adrenergic beta-Agonists; Aerosols; Asthma; Betamethasone; Bronchodilator Agents; Cromolyn Sodium; D

1983